Analyst Ratings for Bicycle Therapeutics (BCYC)
BCYC Rating Summary
BCYC Price Target Summary
- Highest: $36.00 (Oppenheimer)
- Lowest: $7.00 (RBC Capital)
- Average: $13.86
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.86 (+246.4%)
* Over Last 12-Mos
Rating Score: 7.2 / 10
Percentile Rank: 76%
Avg. $ Target:
$13.86 (+246.4%)
* Over Last 12-Mos
Rating Score: 7.2 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/24/2025 | Truist Securities » Updated 5/1/2026 |
Greg Renza | New Coverage | Hold (N/A) |
7.00 (8.00) |
6.32 (4.00) |
-36.71% | Details |
| 10/31/2025 | RBC Capital » Updated 3/18/2026 |
Leonid Timashev | Downgrade | Sector Perform (Outperform) |
7.00 (11.00) |
8.18 (4.00) |
-51.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
